Status:
COMPLETED
Copeptin for Risk Stratification in Non-traumatic Headache in the Emergency Setting - The CoHead Study
Lead Sponsor:
University Hospital, Basel, Switzerland
Conditions:
Head Pain
Eligibility:
All Genders
18+ years
Brief Summary
Headache is a common symptom, and patients often seek medical attention at emergency departments due to headaches. The aim of the CoHead Study is to find out if it is possible by measuring copeptin, ...
Detailed Description
Background: In the emergency setting, non-traumatic headache (NTH) is in 80% a benign symptom, but serious causes have to be ruled out. Copeptin, as a surrogate marker for antidiuretic hormone (ADH),...
Eligibility Criteria
Inclusion
- headache at the time of screening
- Patients must be able to give informed consent
Exclusion
- less than 18 years of age
- preceding (head) trauma
Key Trial Info
Start Date :
October 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2013
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT01174901
Start Date
October 1 2010
End Date
August 1 2013
Last Update
May 26 2014
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Kantonsspital Aarau AG
Aarau, Canton of Aargau, Switzerland, 5001
2
University Hospital of Basel
Basel, Canton of Basel-City, Switzerland, 4031